Sutton Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$23.8K Sell
318
-50
-14% -$3.85K 0.01% 339
2023
Q2
$28.4K Sell
368
-8
-2% -$638 0.01% 300
2023
Q1
$31.2K Sell
376
-1,388
-79% -$115K 0.02% 254
2022
Q4
$151K Sell
1,764
-24
-1% -$1.9K 0.06% 203
2022
Q3
$110K Buy
1,788
+21
+1% +$1.32K 0.04% 236
2022
Q2
$109K Buy
1,767
+12
+0.7% +$743 0.04% 226
2022
Q1
$104K Buy
1,755
+76
+5% +$4.86K 0.04% 243
2021
Q4
$122K Hold
1,679
0.04% 231
2021
Q3
$117K Buy
1,679
+5
+0.3% +$351 0.04% 233
2021
Q2
$115K Hold
1,674
0.04% 237
2021
Q1
$108K Buy
1,674
+11
+0.7% +$709 0.04% 230
2020
Q4
$96.9K Buy
1,663
+51
+3% +$3.08K 0.04% 229
2020
Q3
$102K Sell
1,612
-57
-3% -$3.95K 0.05% 212
2020
Q2
$128K Buy
1,669
+4
+0.2% +$307 0.07% 187
2020
Q1
$124K Buy
1,665
+53
+3% +$3.66K 0.08% 173
2019
Q4
$105K Sell
1,612
-6
-0.4% -$391 0.05% 212
2019
Q3
$103K Hold
1,618
0.06% 207
2019
Q2
$109K Buy
1,618
+4
+0.2% +$263 0.06% 198
2019
Q1
$105K Buy
1,614
+14
+0.9% +$931 0.06% 203
2018
Q4
$100K Hold
1,600
0.06% 193
2018
Q3
$124K Sell
1,600
-7
-0.4% -$529 0.08% 176
2018
Q2
$114K Sell
1,607
-4
-0.2% -$282 0.08% 184
2018
Q1
$121K Hold
1,611
0.09% 176
2017
Q4
$115K Buy
1,611
+6
+0.4% +$456 0.08% 188
2017
Q3
$130K Sell
1,605
-17
-1% -$1.3K 0.1% 168
2017
Q2
$115K Buy
1,622
+64
+4% +$4.26K 0.09% 181
2017
Q1
$106K Sell
1,558
-185
-11% -$13K 0.09% 182
2016
Q4
$125K Buy
1,743
+149
+9% +$11.1K 0.11% 160
2016
Q3
$126K Sell
1,594
-73
-4% -$5.93K 0.12% 153
2016
Q2
$139K Sell
1,667
-678
-29% -$60.2K 0.13% 137
2016
Q1
$215K Buy
+2,345
New +$211K 0.2% 84

Other funds holding GILD

Sutton Wealth Advisors's GILD Position: Q3 2023 in Review

Sutton Wealth Advisors reduced its Gilead Sciences (GILD) stake by 14% in Q3 2023, selling an estimated $3.85K and leaving 318 shares worth $23.8K. The position accounts for 0.01% of the portfolio, ranked #339.

Sutton Wealth Advisors first reported a position in GILD in Q1 2016 and has held it in 31 quarters since. The position peaked at $215K in Q1 2016. 1,682 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

  • Sutton Wealth Advisors held 318 shares of Gilead Sciences worth $23.8K as of Q3 2023.
  • Sutton Wealth Advisors sold 50 Gilead Sciences shares in Q3 2023, an estimated $3.85K.
  • Gilead Sciences made up 0.01% of Sutton Wealth Advisors's portfolio in Q3 2023, its #339 holding.
  • Sutton Wealth Advisors first reported a position in Gilead Sciences in Q1 2016 and has held it in 31 quarters since.
  • Sutton Wealth Advisors's Gilead Sciences position peaked at $215K in Q1 2016.
  • 1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Sutton Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.